CIK 0000759944
CFG CITIZENS FINANCIAL GROUP INC/RI
Insider trading from SEC Form 4. Last filing Dec 2, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company
Signals
Open-market buys and sells at CITIZENS FINANCIAL GROUP INC/RI, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 46Moderate | sell | Cummings Kevin director | $167k | 4,254 | -100% | - |
Congressional trades
1 trade in CFG disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Jefferson Shreve House · R-IN | Sale | CFG Citizens Financial Group, Inc. Common Stock | $15k to $50k | Apr 7, 2025 | 31 days after the trade |
Transactions
The last 19 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | MCCREE DONALD H III Head of Commercial Banking | GGift Common Stock | -11,129 | $0.00 | $0 | 170,566 | Dec 2, 2024 |
| Nov 13, 2024 | Alexander Lee director | AGrant or award Common Stock | +162 | $0.00 | $0 | 18,100 | Nov 15, 2024 |
| Nov 13, 2024 | Watson Wendy A. director | AGrant or award Common Stock | +309 | $0.00 | $0 | 46,916 | Nov 15, 2024 |
| Nov 13, 2024 | Leary Robert G director | AGrant or award Common Stock | +226 | $0.00 | $0 | 25,179 | Nov 15, 2024 |
| Nov 13, 2024 | KELLY EDWARD J III director | AGrant or award Common Stock | +278 | $0.00 | $0 | 30,966 | Nov 15, 2024 |
| Nov 13, 2024 | Lillis Terrance director | AGrant or award Common Stock | +278 | $0.00 | $0 | 30,966 | Nov 15, 2024 |
| Nov 13, 2024 | Cumming Christine M director | AGrant or award Common Stock | +309 | $0.00 | $0 | 43,787 | Nov 15, 2024 |
| Nov 13, 2024 | ZURAITIS MARITA director | AGrant or award Common Stock | +309 | $0.00 | $0 | 48,916 | Nov 15, 2024 |
| Nov 13, 2024 | Swift Christopher director | AGrant or award Common Stock | +162 | $0.00 | $0 | 18,100 | Nov 15, 2024 |
| Nov 13, 2024 | Cummings Kevin director | AGrant or award Common Stock | +124 | $0.00 | $0 | 466,009 | Nov 15, 2024 |
| Nov 13, 2024 | HANKOWSKY WILLIAM P director | AGrant or award Common Stock | +309 | $0.00 | $0 | 71,998 | Nov 15, 2024 |
| Nov 13, 2024 | SIEKERKA MICHELE N director | AGrant or award Common Stock | +124 | $0.00 | $0 | 58,484 | Nov 15, 2024 |
| Nov 13, 2024 | Atkinson Tracy A director | AGrant or award Common Stock | +47 | $0.00 | $0 | 5,280 | Nov 15, 2024 |
| Feb 14, 2024 | SIEKERKA MICHELE N director | LSmall acquisition Common Stock | +12 | $32.31 | $386 | 58,496 | Nov 15, 2024 |
| Dec 30, 2022 | Cummings Kevin director | SOpen-market sale Common Stockindirect: By 401K | -4,254 | $39.32 | $167k | 0 | Nov 15, 2024 |
| May 15, 2024 | SIEKERKA MICHELE N director | LSmall acquisition Common Stock | +11 | $36.14 | $391 | 58,506 | Nov 15, 2024 |
| Aug 14, 2024 | SIEKERKA MICHELE N director | LSmall acquisition Common Stock | +10 | $39.62 | $395 | 58,516 | Nov 15, 2024 |
| Nov 1, 2024 | Schnirel Christopher J Chief Accounting Officer | AGrant or award Common Stock | +7,590 | $0.00 | $0 | 7,590 | Nov 4, 2024 |
| Oct 24, 2024 | VAN SAUN BRUCE Chairman and CEO | GGift Common Stock | -8,035 | $0.00 | $0 | 1,147,822 | Oct 25, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Alexander Leedirector
- Atkinson Tracy Adirector
- Cumming Christine Mdirector
- Cummings Kevindirector
- HANKOWSKY WILLIAM Pdirector
- KELLY EDWARD J IIIdirector
- Leary Robert Gdirector
- Lillis Terrancedirector
- MCCREE DONALD H IIIHead of Commercial Banking
- SIEKERKA MICHELE Ndirector
- Schnirel Christopher JChief Accounting Officer
- Swift Christopherdirector
- VAN SAUN BRUCEChairman and CEO
- Watson Wendy A.director
- ZURAITIS MARITAdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.